KL2 Program
Career development grants for instructors and assistant professors
Directors: Jon Tyson, MD, MPH and Charles C. Miller, PhD
Contact Person:
The CCTS KL2 program supports the training and career development of UT instructors and assistant professors (with MD, DO, DDS, DSN,
All applicants must be engaged in or preparing to conduct clinical or translational research and must be able to complete the entire funding period at UTHealth. Each applicant's department chair must confirm that the applicant will have protected time commensurate with the percent salary support the KL2 program will supply. (In calculating percent protected time, the denominator must be the total institutional activities for which an individual is compensated by his or her institution. This includes time in
Each trainee will conduct a research study under the supervision of a senior faculty mentor and complete the core curriculum at UTHealth Clinical Research Curriculum. Trainees will also propose and complete individualized career development plans that include a statement of career goals and any additional training (beyond the core curriculum) that will be undertaken to complete them.
THE KL2 PROGRAM IS CURRENTLY NOT ACCEPTING APPLICATIONS.
DEADLINE FOR SUBMISSION IS May 13, 2019.
Next round of KL2 Scholar Award Applications will be announced Spring 2020.
PLEASE CONTACT MICQUELYLN TITUS FOR MORE INFORMATION AND FOR THE APPLICATION FORM
Scholar/Affiliation | Title of Project/Mentors | Years in Program |
---|---|---|
Nneka Ifejika, MD |
Swipe Out Stroke (SOS): Feasibility of Using a Consumer-Based Electronic Application to Improve Compliance with Weight Loss in Obese Minority Stroke Patients |
2014- |
Mike Liang, MD |
Modifying Risk in Ventral Hernia Patients |
2014- |
Ricardo Mosquera, MD |
Home-Centered Comprehensive Care (HCCC) for Children with Severe Asthma: A Pilot Trial |
2014- |
Absalon Gutierrez, MD |
Killing Several Birds with One Stone: Comparative Effects of Antidiabetic Medications on Postprandial Hyperlipidemia, Free Fatty Acid Signaling, and Endothelial Dysfunction in Individuals with Prediabetes |
2013- |
Sheng Luo, PhD |
Innovative Statistical Methods for Analyzing Parkinson’s Disease Study Data |
2013- |
Amber Luong, MD, PhD |
Randomized Double-Blinded Controlled Trial of Oral Antifungal for the Treatment of Fungal Sensitive Chronic Rhinosinusitis with Nasal Polyps |
2013- |
Anka Vujanovic, PhD |
Randomized Controlled Trial of a Novel Cognitive-Behavioral Treatment for PTSD and Cocaine Dependence |
2013- |
Allison McCoy, PhD |
InSPECT: Interactive Surveillance Portal for Evaluating Clinical Decision Support |
2012-2013 |
Siddharth Prakash, MD, PhD |
Validation and Replication of Genetic Variants Associated with Bicuspid Aortic Valve in Turner Syndrome |
2012- |
Joyce Samuel, MD, MS |
Series of n-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents with Essential Hypertension |
2012- |
Andrew Barreto, MD |
The Safety and Efficacy of Argatroban and TPA in Acute Ischemic Stroke |
2010-2013 |
Laura Benjamins, MD MPH |
Prevalence of Human Papillomavirus Infection among HIV-Exposed Infants |
2010-2014 |
Sherwin Assassi, MD |
Gene Expression Predictors of Outcome in Systemic Sclerosis |
2009-2011 |
Isabel Gay, DDS, MS |
|
2009-2012 |
Kevin Hwang, MD, MPH |
Promoting Colorectal Cancer Screening among Members of Internet Health Communities |
2009-2012 |
Sunil Krishnan, MD |
Optimizing the Combination of Gold Nanoparticles and Radiation Therapy |
2009-2012 |
Shaper Mirza, PhD |
Relationship between Immune Dysregulation and Nasal Carriage of Streptococcus |
2009-2012 |
Jeremy Schaefer, PhD |
Evaluation of miRNAs in Peripheral Blood Leukocytes and Intestine in Crohn’s Disease Patients: Implication for Diagnosis and Therapy |
2009-2012 |
Erik Sulman, MD, PhD |
Functional Analysis of Podoplanin in the Treatment Resistance of Glioma Stem Cells |
2008-2011 |
Jerrie Refuerzo, MD |
Developing, Evaluating, and Applying Nanotherapeutics to Improve the Outcome of High-Risk Pregnancies |
2008-2011 |
Niton Tandon, MD |
A Cross-modal Synthetic Approach to Eloquent Cortical Regions |
2008-2011 |
Kuojen Tsao, MD |
The Role of Anti-reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants with Bronchopulmonary Dysplasia |
2008-2010 |
Susan Wootton, MD |
GI Shedding of Human Influenza Virus in Hospitalized Children |
2008-2011 |
Kenneth Helmer, MD |
The Anti-Inflammatory Role of Ketamine in Thoracoabdominal Aortic Aneurysm Repair |
2007-2008 |
Mary Kay Koenig, MD |
Contribution of Mitochondrial Membrane Uncoupling to Heteroplasmic Shift during Ketogenic Incubation of Mutated mDNA Cells In Vitro |
2007-2010 |
Elizabeth Plimack, MD |
Efficacy and Toxicity of Decitabine Combined with IFN alfa-2b in Patients with Advanced Renal Cell Carcinoma |
2007-2008 |
Mary Ruppe, MD |
Growth Determinants in X-Linked Hypophosphatemic Rickets |
2007-2010 |
Kerri Smith, PhD |
Induction of Tolerance Using a Covalent Analog of Factor VIII |
2007-2010 |
Wendy Woodward, MD, PhD |
Radiation Resistance of Human Mammary Stem/ Progenitor Cells in the Immortalized Human Breast Cancer Cell Line MCF-7 |
2007-2010 |
Scott Evans, MD |
Evaluation of Pulmonary Epithelial Cells and Alveolar Macrophages Will Predict the Etiology of Infectious Pneumonias |
2007-2010 |
Nicole Gonzales, MD |
A Pilot Trial of PPAR-y Agonist to Accelerate Hematoma Resolution in Intracerebral Hemorrhage |
2007-2010 |
Jay Murthy, MD
|
Comparative Expression Proteomics of Bronchoalveolar Lavage Fluid and Serum in Patients with Diffuse Systemic Sclerosis-Associated Interstitial Lung Disease and a Novel Scleroderma Mouse Model |
2007-2010 |
Claudia Pedroza, PhD |
Use of Bayesian Methods for Analyses of Center Differences |
2007-2010 |
Christopher Pelloski, MD |
Mechanisms and Prognostic Significance of YKL-40 Induced Gene Expression and Phenotypic Changes in Malignant Glioma |
2007-2010 |
Amado Zurita-Saavedra, MD |
Developing Osteoblast Cadherin (Ob-Cadherin) as a Biomarker and Therapeutic Target in Prostate Cancer Metastasis |
2007-2010 |
CCTS Trainees, Scholars, and Associate Members Dinner
The CCTS’s TL1 trainees, KL2 scholars, and associate members (new investigators supported by the CCTS through other mechanisms) met to discuss their research and forge new collaborations. Many were surprised at the common themes among studies being performed in different CCTS institutions. For instance, several MD Anderson and UTHealth investigators realized they all were addressing aspects of inflammation.
![]() |
![]() |
(above) John McAuliffe (TL1 trainee and student in the PhD program in Patient-Based Biological Research; Sarcoma Medical Oncology, UT MD Anderson Cancer Center); Ashley Hood |
(above) Eyal Muscal, |
![]() |
![]() |
(above) Eyal Muscal, MD (CCTS associate member and student in the Masters Program in Clinical Research; Pediatrics/Rheumatology, Baylor College of Medicine); Kenneth Helmer, MD (KL2 scholar; Surgery, UTHealth Medical School); Lillian Kao, MD, MS (CCTS associate member and graduate of the Masters Program in Clinical Research; Surgery, UTHealth Medical School); Sherwin Assassi, MD (CCTS associate member and student in the Masters Program in Clinical Research; Rheumatology, UTHealth Medical School); Frank Arnett, MD (Executive Director, CCTS); Jayasimha Murthy, MD (KL2 scholar; Pulmonary and Critical Care Medicine, UTHealth Medical School). |
(above) Kamal Busaidy, DDS (CCTS associate member and student in the Masters Program in Clinical Research; Oral Maxillofacial Surgery, UTHealth Dental Branch), discusses his work on osteonecrosis of the jaw due to bisphosphonate treatment, a therapy for some cancers. |